Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Phase II Study of Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancer
Brief Summary: This study is designed to see whether Apatinib is effective in treating patients with advanced refractory biliary tract cancers.